The Men's Health Foundation is one of nine Centers of Excellence for Biomedical Prevention Services (PEP/PrEP) in Los Angeles County. With a robust research division, its comprehensive care clinic, the Southern [...]
After tens of thousands of PrEP successes, the first documented case of someone becoming poz includes rare multiclass drug resistance.
It’s been nearly two years since the Centers for Disease Control and Prevention issued historic guidelines recommending that thousands of Americans—particularly gay and bi men, transgender women, injection drug users, and partners of HIV-positive individuals—start taking Truvada as pre-exposure prophylaxis (or PrEP) to prevent HIV infection.
This Tuesday, the Men's Health Foundation attended the "EMPOWE[RED]: Getting to zero, a generation free of HIV" event at Mark Taper Auditorium, December 1, 2015 (World AIDS Day). Health organizations and community [...]
The U.S. Food and Drug Administration today approved Genvoya (a fixed-dose combination tablet containing elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide) as a complete regimen for the treatment of HIV-1 infection in [...]